IRadimed Corporation (IRMD) DCF Valuation

IRadimed Corporation (IRMD) DCF Valuation

US | Healthcare | Medical - Devices | NASDAQ
IRadimed Corporation (IRMD) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

IRadimed Corporation (IRMD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the IRadimed Corporation (IRMD) DCF Calculator! Review authentic financials for Apple, adjust growth projections and expenses, and instantly observe how these changes affect the intrinsic value of IRadimed Corporation (IRMD).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 38.5 31.7 41.8 53.3 65.6 76.2 88.5 102.8 119.4 138.7
Revenue Growth, % 0 -17.65 31.83 27.48 23 16.16 16.16 16.16 16.16 16.16
EBITDA 9.9 .6 11.2 16.3 20.8 17.8 20.6 24.0 27.9 32.4
EBITDA, % 25.68 1.84 26.84 30.58 31.73 23.33 23.33 23.33 23.33 23.33
Depreciation .6 .6 .6 .7 .8 1.1 1.3 1.5 1.8 2.0
Depreciation, % 1.53 1.9 1.52 1.26 1.17 1.48 1.48 1.48 1.48 1.48
EBIT 9.3 .0 10.6 15.6 20.0 16.6 19.3 22.5 26.1 30.3
EBIT, % 24.14 -0.06578099 25.33 29.32 30.56 21.86 21.86 21.86 21.86 21.86
Total Cash 46.3 52.0 62.5 58.0 49.8 72.5 84.2 97.8 113.6 132.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 7.3 4.6 5.1 13.3 12.2
Account Receivables, % 18.94 14.42 12.28 24.9 18.65
Inventories 3.6 3.9 4.3 5.4 12.8 9.4 10.9 12.7 14.7 17.1
Inventories, % 9.45 12.4 10.28 10.07 19.56 12.35 12.35 12.35 12.35 12.35
Accounts Payable 1.0 .7 .8 1.8 1.9 1.9 2.3 2.6 3.0 3.5
Accounts Payable, % 2.58 2.07 1.87 3.38 2.83 2.55 2.55 2.55 2.55 2.55
Capital Expenditure -.5 -.6 -.7 -1.9 -8.0 -3.2 -3.7 -4.3 -5.0 -5.8
Capital Expenditure, % -1.26 -2.01 -1.77 -3.52 -12.21 -4.15 -4.15 -4.15 -4.15 -4.15
Tax Rate, % 20.91 20.91 20.91 20.91 20.91 20.91 20.91 20.91 20.91 20.91
EBITAT 9.9 .0 10.0 12.4 15.8 11.8 13.7 15.9 18.4 21.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .1 2.1 9.1 3.0 2.3 11.9 7.9 9.2 10.6 12.4
WACC, % 8.21 8.2 8.21 8.21 8.21 8.21 8.21 8.21 8.21 8.21
PV UFCF
SUM PV UFCF 41.0
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 13
Terminal Value 306
Present Terminal Value 206
Enterprise Value 247
Net Debt -48
Equity Value 295
Diluted Shares Outstanding, MM 13
Equity Value Per Share 23.17

What You Will Receive

  • Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-entered real IRMD financials.
  • Authentic Data: Historical figures and future projections (highlighted in the yellow cells).
  • Flexible Forecasting: Adjust forecast variables such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect IRadimed’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Centric Layout: Organized for clarity and simplicity, complete with step-by-step guidance.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for IRadimed Corporation (IRMD).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specifically for IRMD.
  • Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates relevant to IRadimed Corporation (IRMD).
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios pertinent to IRadimed Corporation (IRMD).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of IRadimed Corporation (IRMD).

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered IRadimed Corporation (IRMD) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for IRadimed Corporation’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for IRadimed Corporation (IRMD)?

  • Designed for Industry Experts: A sophisticated tool tailored for analysts, CFOs, and healthcare consultants.
  • Up-to-Date Financial Data: IRadimed's historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly Interface: Step-by-step guidance ensures a smooth calculation process.

Who Should Use IRadimed Corporation (IRMD) Products?

  • Healthcare Providers: Enhance patient care with advanced MRI-compatible infusion systems.
  • Biomedical Engineers: Utilize cutting-edge technology to innovate and improve medical devices.
  • Medical Consultants: Tailor solutions for clients in the healthcare sector with ease.
  • Investors: Analyze the potential of a growing company in the medical device market.
  • Students and Educators: Explore real-world applications of medical technology in academic settings.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations for IRadimed Corporation (IRMD).
  • Real-World Data: IRadimed’s historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test scenarios specific to IRMD.
  • Financial Statements: Full annual and quarterly breakdowns for deeper insights into IRadimed's performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage tailored to IRMD.
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results regarding IRadimed Corporation (IRMD).

No products were found matching.